FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

398840005: Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin (medicinal product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3523565011 Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin (medicinal product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3523567015 Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3695215012 Neomycin sulfate and polymyxin B sulfate and zinc bacitracin product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3840711000005112 bacitracinzink + neomycinsulfat + polymyxin B-sulfat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing bacitracin (medicinal product) false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing polymyxin B (medicinal product) false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antiinfektiøst middel til huden false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc bacitracin false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulfate false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B sulfate false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing neomycin in ophthalmic dosage form false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing polymyxin B in ophthalmic dosage form false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Bacitracin-containing product in ocular dose form false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing neomycin and polymyxin B (medicinal product) false Inferred relationship Some
    bacitracinzink + neomycinsulfat + polymyxin B-sulfat Is a Product containing bacitracin and polymyxin B (medicinal product) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve Is a False bacitracinzink + neomycinsulfat + polymyxin B-sulfat Inferred relationship Some
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment Is a False bacitracinzink + neomycinsulfat + polymyxin B-sulfat Inferred relationship Some
    Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin Is a False bacitracinzink + neomycinsulfat + polymyxin B-sulfat Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start